临床试验/NCT00656240

NCT00656240

已完成

2 期

A Randomized, Double-Masked, Parallel-Group Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Santen Pharmaceutical Co., Ltd.1 个研究点分布在 1 个国家2008年4月11日

适应症Open-Angle Glaucoma Ocular Hypertension

干预措施DE-104 ophthalmic solution DE-104 vehicle

概览

阶段: 2 期
干预措施: DE-104 ophthalmic solution
疾病 / 适应症: Open-Angle Glaucoma
发起方: Santen Pharmaceutical Co., Ltd.
试验地点: 1
状态: 已完成
最后更新: 17年前

概览研究者入排标准研究组 & 干预措施结局指标研究点相似试验

概览

简要总结

To investigate the intraocular pressure (IOP)-lowering effect and safety of DE-104 ophthalmic solution in patients with Primary Open-Angle Glaucoma or Ocular Hypertension

注册库

clinicaltrials.gov

开始日期

2008年4月11日

结束日期

待定

最后更新

17年前

研究类型

Interventional

性别

All

研究者

发起方

Santen Pharmaceutical Co., Ltd.

入排标准

入选标准

•Diagnosed with primary open-angle glaucoma or ocular hypertension.
•Provided signed, written informed consent.
•If a subject is a female of childbearing potential, she must utilize reliable contraceptive throughout the study, and must have a negative urine pregnancy test prior to enrollment into this study.

排除标准

•Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception.
•Presence of any abnormality or significant illness that could be expected to interfere with the study.

研究组 & 干预措施

1

干预措施: DE-104 ophthalmic solution

2

干预措施: DE-104 vehicle

结局指标

主要结局

未指定

研究点 (1)

Loading locations...

相似试验

已完成

2 期

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension

NCT00657579Santen Pharmaceutical Co., Ltd.

已完成

2 期

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension

NCT00650338Santen Inc.165

已完成

1 期

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension

NCT00868894Santen Inc.49

已完成

3 期

Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract SurgeryCataract Surgery

NCT02573610Santen Pharmaceutical Co., Ltd.576

已完成

4 期

Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)Angle-closure Glaucoma

NCT00762645Alcon Research30